Bluebook
Pharma Services March 2019
2019 - March: Report on M&A and financing activity in the pharma services drug development industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
- Transactions in the Pharma Services – Development industry totaled six mergers & acquisitions and three financings during the month of March
- In terms of M&A, the Clinical Services sector was the most active this month, with 4 M&A transactions; while in terms of financings, the Technology and Information Systems sector was the most active with 3 financings
- Financings totaled $80 million during the month of March
- The largest financing this month was $40 million raised by Saama Technologies, as well as $40 million raised by TriNetX
- M&A and financings in the United States accounted for 83% and 100% of total transactions this month, up 129% and 50%, respectively
- M&A activity this month includes acquisitions by Laboratory Corporation of America, TAKE Solutions, Advarra and ProPharma Group
- Crosstree acted as the exclusive financial advisor to Dataceutics on its strategic sale to TAKE Solutions